ArticleFrontiers in oncology2026

Disitamab vedotin combined with anti-PD-1 antibody in a patient with SMARCA4-mutated gastric cancer: a case report.

Zhongkuo Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.